Plasma pro- and anti-inflammatory cytokines may relate to cocaine use, cognitive functioning, and depressive symptoms in cocaine use disorder

References

• Lipari RN, Park-Lee E. Key substance use and mental health indicators in the united states: results from the 2018 national survey on drug use and health. 2019 [accessed 2019 Oct 15]; https://www.samhsa.gov/data/
   Google Scholar
• Shiels MS, Freedman ND, Thomas D, De Gonzalez AB. Trends in U.S. Drug overdose deaths in non-hispanic black, hispanic, and non-hispanic white persons, 2000-2015 [Internet].Ann Intern Med 2018 [accessed 2018 Apr 4];168:453–55. American College of Physicians. http://annals.org/article.aspx?doi=10.7326/M17-1812.
   PubMed Web of Science ®Google Scholar
• Bough KJ, Amur S, Lao G, Hemby SE, Tannu NS, Kampman KM, Schmitz JM, Martinez D, Merchant KM, Green C, et al. Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology. 2014;39:202–19.
   PubMed Web of Science ®Google Scholar
• Coller JK, Hutchinson MR. Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol Ther [Internet]. 2012 May 1 [accessed 2018 Sep 26];134:219–45. https://www.sciencedirect.com/science/article/pii/S0163725812000289?via%3Dihub
   PubMed Web of Science ®Google Scholar
• Bachi K, Sierra S, Volkow ND, Goldstein RZ, Alia-klein N. Is biological aging accelerated in drug addiction? Curr Opin Behav Sci [Internet]. 2017;13:34–39. 2016 10 25. doi:10.1016/j.cobeha.2016.09.007.
   PubMed Web of Science ®Google Scholar
• Whicher JT, Evans SW. Cytokines in disease. Clinical Chem. 1990;36(7):1269–1281. http://www.ncbi.nlm.nih.gov/pubmed/2197032.
   Google Scholar
• Golia E, Limongelli G, Natale F, Fimiani F, Maddaloni V, Pariggiano I, Bianchi R, Crisci M, D’Acierno L, Giordano R, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014. doi:10.1007/s11883-014-0435-z.
   PubMed Web of Science ®Google Scholar
• King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008. doi:10.1902/jop.2008.080246.
   PubMed Web of Science ®Google Scholar
• Vila N, Castillo J, Dávalos A, Esteve A, Planas AM, Chamorro Á. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003. doi:10.1161/01.STR.0000057976.53301.69.
   Web of Science ®Google Scholar
• Xie W, Fang L, Gan S, Xuan H. Interleukin-19 alleviates brain injury by anti-inflammatory effects in a mice model of focal cerebral ischemia. Brain Res. 2016;1650:172–77. doi:10.1016/j.brainres.2016.09.006.
   PubMed Web of Science ®Google Scholar
• Crews FT, Zou J, Qin L. Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun [Internet]. 2011;25:S4–12. http://www.sciencedirect.com/science/article/pii/S0889159111000717
   PubMed Web of Science ®Google Scholar
• Marasco CC, Goodwin CR, Winder DG, Schramm-Sapyta NL, McLean JA, Wikswo JP, Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems. Exp Biol Med [Internet].2014.http://ebm.sagepub.com/content/early/2014/06/04/1535370214537747.abstract
   Web of Science ®Google Scholar
• Harricharan R, Abboussi O, Daniels WMU. Addiction: A dysregulation of satiety and inflammatory processes. Prog Brain Res. 2017;235:65–91.
   PubMed Web of Science ®Google Scholar
• Cui C, Shurtleff D, Harris RA. Neuroimmune mechanisms of alcohol and drug addiction. Int Rev Neurobiol. 2014;118:1–12.
   PubMed Web of Science ®Google Scholar
• Maza-Quiroga R, Garcia-Marchena N, Romero-Sanchiz P, Barrios V, Pedraz M, Serrano A, Nogueira-Arjona R, Ruiz JJ, Soria M, Campos R, et al. Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFalpha) as a potential biomarker of consumption and dual diagnosis. PeerJ. 2017;5:e3926.
   PubMed Web of Science ®Google Scholar
• Araos P, Pedraz M, Serrano A, Lucena M, Barrios V, Garcia-Marchena N, Campos-Cloute R, Ruiz JJ, Romero P, Suárez J, et al. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. Addict Biol. 2015 Jul;20:756–72. doi:10.1111/adb.12156.
   PubMed Web of Science ®Google Scholar
• Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 2003. doi:10.1016/S0376-8716(03)00092-9.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Mooney ME, Green CE, Lane SD, Steinberg JL, Swann AC, Moeller FG. Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial. J Addict Dis. 2009. doi:10.1080/10550880903028502.
   PubMed Web of Science ®Google Scholar
• Turner TH, LaRowe S, Horner MD, Herron J, Malcolm R. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009. doi:10.1016/j.jsat.2009.03.009.
   PubMed Web of Science ®Google Scholar
• Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend [Internet]. 2006 Feb 28 [accessed 2018 Sep 5];81:313–22. https://www.sciencedirect.com/science/article/pii/S0376871605002516
   PubMed Web of Science ®Google Scholar
• Brown RA, Monti PM, Myers MG, Martin RA, Rivinus T, Ella Dubreuil M, Rohsenow DJ. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome. American J. Psychiatry. 1998;155(2):220–225. doi:10.1176/ajp.155.2.220.
   Google Scholar
• Wardle MC, Vincent JN, Suchting R, Green CE, Lane SD, Schmitz JM. Anhedonia is associated with poorer outcomes in contingency management for cocaine use disorder. J Subst Abuse Treat. 2017;72:32–39. doi:10.1016/j.jsat.2016.08.020
   PubMed Web of Science ®Google Scholar
• Liao K, Guo M, Niu F, Yang L, Callen SE, Buch S. Cocaine-mediated induction of microglial activation involves the ER stress-TLR2 axis. J Neuroinflammation. 2016. doi:10.1186/s12974-016-0501-2.
   Web of Science ®Google Scholar
• Loftis JM, Huckans M. Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy [Internet]. Pharmacol Therapeutics Pergamon. 2013 [accessed 2018 Feb 15];139:289–300. https://www.sciencedirect.com/science/article/pii/S0163725813001010
   PubMed Web of Science ®Google Scholar
• Ersche KD, Döffinger R. Inflammation and infection in human cocaine addiction. Curr Opin Behav Sci [Internet]. 2017;13:203–09. http://www.sciencedirect.com/science/article/pii/S2352154616302704
   Web of Science ®Google Scholar
• Moreira FP, Medeiros JRC, Lhullier AC, Souza LD de M, Jansen K, Portela LV, Lara DR, Silva RAD, Wiener CD, Oses JP, et al. Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. Drug Alcohol Depend [Internet]. 2016 Jan;158:181–85. 2015/12/19. http://linkinghub.elsevier.com/retrieve/pii/S0376871615017755
   PubMed Web of Science ®Google Scholar
• Pianca TG, Rosa RL, KMM C, de Aguiar BW, de Abrahão RC, Lazzari PM, Kapczinski F, Pechansky F, Rohde LA, Szobot CM, et al. Differences in biomarkers of crack-cocaine adolescent users before/after abstinence. Drug Alcohol Depend. 2017;177:207–13.
   PubMed Web of Science ®Google Scholar
• Narvaez JCM, P V M, Fries GR, Colpo GD, Czepielewski LS, Vianna P, Chies JAB, Rosa AR, Von Diemen L, Vieta E, et al. Peripheral toxicity in crack cocaine use disorders. Neurosci Lett. 2013;544:80–84.
   PubMed Web of Science ®Google Scholar
• Fox HC, D’Sa C, Kimmerling A, Siedlarz KM, Tuit KL, Stowe R, Sinha R. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum Psychopharmacol. 2012. doi:10.1002/hup.1251.
   Web of Science ®Google Scholar
• Levandowski ML, Hess ARB, Grassi-Oliveira R, de Almeida RMM. Plasma interleukin-6 and executive function in crack cocaine-dependent women. Neurosci Lett [Internet]. 2016 Aug 15 [accessed 2018 Sep 6];628:85–90. https://www.sciencedirect.com/science/article/abs/pii/S0304394016304323
   PubMed Web of Science ®Google Scholar
• Maza-Quiroga R, García-Marchena N, Romero-Sanchiz P, Barrios V, Pedraz M, Serrano A, Nogueira-Arjona R, Ruiz JJ, Soria M, Campos R, et al. Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis. PeerJ. 2017 Oct;12:e3926. doi:10.7717/peerj.3926.
   Web of Science ®Google Scholar
• Trollor JN, Smith E, Agars E, Kuan SA, Baune BT, Campbell L, Samaras K, Crawford J, Lux O, Kochan NA, et al. The association between systemic inflammation and cognitive performance in the elderly: the Sydney memory and ageing study. Age (Omaha). 2012;34:1295–308.
   PubMedGoogle Scholar
• Simen AA, Bordner KA, Martin MP, Moy LA, Barry LC. Cognitive dysfunction with aging and the role of inflammation. Ther Adv Chronic Dis. 2011;2:175–95. doi:10.1177/2040622311399145.
   PubMedGoogle Scholar
• Almeida PP, de Araujo Filho GM, Malta SM, Laranjeira RR, Marques ACRP, Bressan RA, Lacerda ALT Attention and memory deficits in crack-cocaine users persist over four weeks of abstinence. J Subst Abuse Treat. 2017. doi:10.1016/j.jsat.2017.08.002.
   PubMed Web of Science ®Google Scholar
• Vonmoos M, Hulka LM, Preller KH, Minder F, Baumgartner MR, Quednow BB. Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study. Neuropsychopharmacology [Internet]. 2014 Aug 21 [accessed 2018 Sep 12];39:2200–10. http://www.nature.com/articles/npp201471
   PubMed Web of Science ®Google Scholar
• Kelley BJ, Yeager KR, Pepper TH, Beversdorf DQ. Cognitive impairment in acute cocaine withdrawal. Cogn Behav Neurol. 2005. doi:10.1097/01.wnn.0000160823.61201.20.
   PubMed Web of Science ®Google Scholar
• Hope S, Hoseth E, Dieset I, Mørch RH, Aas M, Aukrust P, Djurovic S, Melle I, Ueland T, Agartz I, et al. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls. Schizophr Res [Internet]. 2015 Jul 1 [accessed 2018 Feb 23];165:188–94. https://www.sciencedirect.com/science/article/pii/S0920996415001772?via%3Dihub
   PubMed Web of Science ®Google Scholar
• Huckans M, Fuller BE, Chalker ALN, Adams M, Loftis JM. Plasma inflammatory factors are associated with anxiety, depression, and cognitive problems in adults with and without methamphetamine dependence: an exploratory protein array study. Front Psychiatry. 2015. doi:10.3389/fpsyt.2015.00178.
   PubMed Web of Science ®Google Scholar
• Walss-Bass C, Suchting R, Olvera RL, Williamson DE. Inflammatory markers as predictors of depression and anxiety in adolescents: statistical model building with component-wise gradient boosting. J Affect Disord. 2018;234:276–81. doi:10.1016/j.jad.2018.03.006.
   PubMed Web of Science ®Google Scholar
• Felger JC, Lotrich FE. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199–229. doi:10.1016/j.neuroscience.2013.04.060.
   PubMed Web of Science ®Google Scholar
• Misiak B, Stańczykiewicz B, Kotowicz K, Rybakowski JK, Samochowiec J, Frydecka D. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review. Schizophr Res [Internet]. 2018 Feb accessed 2018 Feb 23;192:16–29. http://www.ncbi.nlm.nih.gov/pubmed/28416092
   PubMed Web of Science ®Google Scholar
• García-Marchena N, Barrera M, Mestre-Pintó JI, Araos P, Serrano A, Pérez-Mañá C, Papaseit E, Fonseca F, Ruiz JJ, Rodríguez de Fonseca F, et al. Inflammatory mediators and dual depression: potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders. PLoS One. 2019 Mar 1;14:e0213791. doi:10.1371/journal.pone.0213791.
   PubMed Web of Science ®Google Scholar
• Rounsaville BJ. Treatment of cocaine dependence and depression. Biol Psychiatry [Internet]. 2004;56:803–09. http://www.sciencedirect.com/science/article/pii/S0006322304005608
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. ( DSM-V); 2014. Washington (DC): Am J Pyschiatry.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. ( DSM-IV); 1994. Washington (DC): Am J Psychiatry.
   Google Scholar
• Zhou X, Fragala MS, McElhaney JE, Kuchel GA. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care [Internet]. 2010 Sep accessed 2018 Mar 7;13:541–47. http://www.ncbi.nlm.nih.gov/pubmed/20657280
   PubMed Web of Science ®Google Scholar
• McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat. 1992 Jun;9:199–213. doi:10.1016/0740-5472(92)90062-S.
   PubMed Web of Science ®Google Scholar
• Shipley WC, Gruber CP, Martin TA, Klein AM, Kaya F, Delen E. ReviewJournal of psychoeducational assessment test review. J Psychoeduc Assess [Internet]. 2012;30:593–97. http://jpa.sagepub.com
   Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. 2nd ed. San Antonio (TX): Psychological Corporation.
   Google Scholar
• Belzeaux R, Lefebvre MN, Lazzari A, Le Carpentier T, Lou CJ, Zendjidjian X, Abbar M, Courtet P, Naudin J, Boucraut J, et al. How to: measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays. Psychoneuroendocrinology. 2017 Jan 1:72–82. doi:10.1016/j.psyneuen.2016.10.010.
   Web of Science ®Google Scholar
• Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn. 2001;28:481–504. doi:10.1023/A:1012299115260.
   PubMed Web of Science ®Google Scholar
• Senn S, Holford N, Hockey H. The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation. Stat Med [Internet]. 2012 Dec 30;31:4280–95. doi:10.1002/sim.5515.
   PubMed Web of Science ®Google Scholar
• Little RJA. Missing-data adjustments in large surveys. J Bus Econ Stat [Internet]. 1988 Jul [accessed 2018 Sep 12];6:287. https://www.jstor.org/stable/1391878?origin=crossref
   Web of Science ®Google Scholar
• Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B Statistical Methodol [Internet]. 2005 Apr 1 [accessed 2018 Sep 12];67:301–20. doi:10.1111/j.1467-9868.2005.00503.x.
   Google Scholar
• Bunea F. Honest variable selection in linear and logistic regression models via ℓ1 and ℓ1+ℓ2 penalization. Electron J Stat [Internet]. 2008 [accessed 2018 Sep 12];2:1153–94. http://projecteuclid.org/euclid.ejs/1229450666
   Web of Science ®Google Scholar
• Jeong J, Kim C. Effect of outliers on the variable selection by the regularized regression. Commun Stat Appl Methods [Internet]. 2018 Mar 31 [accessed 2020 Feb 13];25:235–43. http://www.csam.or.kr/journal/view.html?doi=10.29220/CSAM.2018.25.2.235
   Web of Science ®Google Scholar
• Walss-Bass C, Suchting R, Olvera RL, Williamson DE. Inflammatory markers as predictors of depression and anxiety in adolescents: statistical model building with component-wise gradient boosting. J Affect Disord. 2018 Jul 1;234:276–81. doi:10.1016/j.jad.2018.03.006.
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw [Internet]. 2010 [accessed 2018 Sep 12];33:1–22. http://www.ncbi.nlm.nih.gov/pubmed/20808728
   PubMed Web of Science ®Google Scholar
• Kuhn M. Building predictive models in r using the caret package. J Stat Softw. 2008;28:1–26. doi:10.18637/jss.v028.i05.
   PubMed Web of Science ®Google Scholar
• Kuhn M, Johnson K. Applied predictive modeling. New York: Springer; 2013.
   Google Scholar
• Fillman SG, Sinclair D, Fung SJ, Webster MJ, Shannon Weickert C. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry. 2014 Feb 25;4. doi:10.1038/tp.2014.8.
   PubMed Web of Science ®Google Scholar
• Pagliaccetti NE, Eduardo R, Kleinstein SH, Mu XJ, Bandi P, Robek MD. Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J Biol Chem. 2008 Oct 31;283:30079–89. doi:10.1074/jbc.M804296200.
   PubMed Web of Science ®Google Scholar
• Hemann EA, Gale M, Savan R. Interferon lambda genetics and biology in regulation of viral control. Front Immunol [Internet]. 2017 Dec 6 [accessed 2019 Nov 14];8:1707. http://journal.frontiersin.org/article/10.3389/fimmu.2017.01707/full
   PubMed Web of Science ®Google Scholar
• Jõgeda E, Avi R, Pauskar M, Kallas E, Karki T, Des Jarlais D, Uusküla A, Toompere K, Lutsar I, Huik K, et al. Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs. J Med Virol [Internet]. 2018 Nov 16 [accessed 2019 Nov 14];90:1779–83. http://www.ncbi.nlm.nih.gov/pubmed/29992584
   PubMed Web of Science ®Google Scholar
• Rojo-Martínez G, Maymó-Masip E, Mar Rodríguez M, Solano E, Goday A, Soriguer F, Valdes S, Chaves FJ, Delgado E, Colomo N, et al. Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the [email protected] Study. PLoS One. 2014 Jun 30;9:e101250.
   Web of Science ®Google Scholar
• Zhi Y, Gao P, Xin X, Li W, Ji L, Zhang L, Zhang X, Zhang J. Clinical signifcance of sCD163 and its possible role in asthma (Review). Mol Med Rep. 2017;15:2931–39. Spandidos Publications. doi:10.3892/mmr.2017.6393.
   PubMed Web of Science ®Google Scholar
• Carrico AW, Cherenack EM, Roach ME, Riley ED, Oni O, Dilworth SE, Shoptaw S, Hunt P, Roy S, Pallikkuth S, et al. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS [Internet]. 2018 Mar 27;32:767–71. http://www.ncbi.nlm.nih.gov/pubmed/29369159
   PubMed Web of Science ®Google Scholar
• Catts VS, Weickert C. Gene expression analysis implicates a death receptor pathway in schizophrenia pathology. PLoS One. 2012;7:4. doi:10.1371/journal.pone.0035511.
   Web of Science ®Google Scholar
• Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, Park HS. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy Eur J Allergy Clin Immunol. 2010;65:338–46. doi:10.1111/j.1398-9995.2009.02158.x.
   Web of Science ®Google Scholar
• Powell TR, McGuffin P, D’Souza UM, Cohen-Woods S, Hosang GM, Martin C, Matthews K, Day RK, Farmer AE, Tansey KE, et al. Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients. PLoS One. 2014;9:e91076.
   PubMed Web of Science ®Google Scholar
• Brietzke E, Kauer-Sant’Anna M, Teixeira AL, Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder. Brain Behav Immun. 2009;23:1079–82. doi:10.1016/j.bbi.2009.04.008.
   PubMed Web of Science ®Google Scholar
• Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM, Ferm M, Dean RA, Simon AJ, Swenson F, et al. Plasma biomarkers associated with the apolipoprotein E genotype and alzheimer disease. Arch Neurol. 2012. doi:10.1001/archneurol.2012.1070.
   Google Scholar
• Wild E, Magnusson A, Lahiri Swales N, Krus U, Orth M, Tabrizi SJ, Björkqvist M. Abnormal peripheral chemokine profile in Huntington’s disease. PLoS Curr. 2011;3:RRN1231.
   PubMedGoogle Scholar
• Levandowski ML, Viola TW, Wearick-Silva LE, Wieck A, Tractenberg SG, Brietzke E, Bauer ME, Teixeira AL, Grassi-Oliveira R Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal. J Psychiatr Res [Internet]. 2014;53:180–86. 2014/03/19. doi:10.1016/j.jpsychires.2014.02.017.
   PubMed Web of Science ®Google Scholar
• Poole JC, Kim HS, Dobson KS, Hodgins DC. Adverse childhood experiences and disordered gambling: assessing the mediating role of emotion dysregulation. J Gambl Stud. 2017 Dec;33:1187–200. doi:10.1007/s10899-017-9680-8.
   PubMed Web of Science ®Google Scholar
• Martinez JM, Garakani A, Yehuda R, Gorman JM. Proinflammatory and “resiliency” proteins in the CSF of patients with major depression. Depress Anxiety. 2012 Jan;29:32–38. doi:10.1002/da.20876.
   PubMed Web of Science ®Google Scholar
• Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord [Internet]. 2015 Jun 11;16:93–98. http://link.springer.com/10.1007/s11154-014-9307-7
   PubMed Web of Science ®Google Scholar
• Khan F, Mukhtar S, Anjum F, Tripathi B, Sriprasad S, Dickinson IK, Madaan S. Fournier’s gangrene associated with intradermal injection of cocaine. J Sex Med. 2013 Apr;10:1184–86. doi:10.1111/jsm.12055.
   PubMed Web of Science ®Google Scholar
• Yazıcı AE, Bagis S, Ş T, Sahin G, Yazıcı K, Erdogan C. Bone mineral density in premenopausal women with major depression. Jt Bone Spine [Internet]. 2005 Dec 1 [accessed 2019 Sep 25];72:540–43. https://www.sciencedirect.com/science/article/pii/S1297319X05000849?via%3Dihub
   PubMed Web of Science ®Google Scholar
• Malik P, Gasser RW, Moncayo RC, Kandler C, Koudouovoh-Tripp P, Giesinger J, Sperner-Unterweger B. Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. Prog Neuro-Psychopharmacol Biol Psychiatry Internet]. 2013 Jul 1 [accessed 2019 Sep 25];44:58–63. https://www.sciencedirect.com/science/article/pii/S0278584613000213?via%3Dihub
   PubMed Web of Science ®Google Scholar
• Boerrigter D, Weickert TW, Lenroot R, O’Donnell M, Galletly C, Liu D, Burgess M, Cadiz R, Jacomb I, Catts VS, et al. Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. J Neuroinflammation. 2017;14:1–15.
   PubMed Web of Science ®Google Scholar
• Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, Le NA, Feinberg R, Tansey MG, Miller AH. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry [Internet]. 2018. http://www.ncbi.nlm.nih.gov/pubmed/29895893
   PubMed Web of Science ®Google Scholar